Home › Therapeutic areas › Oncology › T-Cell Lymphoma

T-Cell Lymphoma (3 companies)

Companies with an active program in T-Cell Lymphoma.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ACRV Acrivon Therapeutics GI/HepatologyOncology Rare 1 Phase 2 $61.4M 9
ARTV Artiva Biotherapeutics Oncology 1 Phase 1 $191M 6
SLS SELLAS Life Sciences Group Oncology 1 Phase 3 $3.90B 9